CynergisTek Inc (NYSEAMERICAN:CTEK) saw a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 8,000 shares, a growth of 63.3% from the April 30th total of 4,900 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average daily volume of 36,200 shares, the days-to-cover ratio is presently 0.2 days.

Shares of CynergisTek stock traded down $0.09 on Monday, reaching $4.75. 2,328 shares of the company were exchanged, compared to its average volume of 25,472. CynergisTek has a fifty-two week low of $3.23 and a fifty-two week high of $5.00.

CynergisTek (NYSEAMERICAN:CTEK) last issued its earnings results on Monday, May 13th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.03). The business had revenue of $5.77 million during the quarter, compared to the consensus estimate of $5.84 million.

Several hedge funds have recently made changes to their positions in CTEK. Perritt Capital Management Inc. increased its holdings in CynergisTek by 7.2% during the 4th quarter. Perritt Capital Management Inc. now owns 567,510 shares of the company’s stock valued at $2,690,000 after purchasing an additional 37,875 shares in the last quarter. Essex Investment Management Co. LLC bought a new position in shares of CynergisTek in the 4th quarter worth $181,000. Acadian Asset Management LLC bought a new position in CynergisTek during the fourth quarter worth about $27,000. Vanguard Group Inc lifted its holdings in CynergisTek by 30.2% during the third quarter. Vanguard Group Inc now owns 98,036 shares of the company’s stock worth $377,000 after acquiring an additional 22,722 shares in the last quarter. Finally, Perkins Capital Management Inc. bought a new position in CynergisTek during the first quarter worth about $124,000.

A number of equities research analysts have recently weighed in on the company. B. Riley reiterated a “buy” rating on shares of CynergisTek in a report on Tuesday, April 2nd. Zacks Investment Research upgraded CynergisTek from a “sell” rating to a “hold” rating in a research report on Tuesday, June 4th.

TRADEMARK VIOLATION NOTICE: “CynergisTek Inc (NYSEAMERICAN:CTEK) Short Interest Up 63.3% in May” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at

CynergisTek Company Profile

Cynergistek, Inc provides outsourced document solutions, IT consulting data security, and managed print services primarily to the healthcare industry in the United States. The company offers Incident Response, Vendor Security Management, and Patient Privacy Monitoring Service, as well as Compliance Assist Partner Program.

Further Reading: Earnings Per Share

Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with's FREE daily email newsletter.